Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x

Contributed by: Business Wire

Logo

Images

K Navigator home screen.

Spatial visualization

Business Wire embedded0

Tags

Data Management

Stem Cells

Other Science

Technology

Research

Data Analytics

Other Health

Pharmaceutical

Oncology

Health Technology

Genetics

Professional Services

Artificial Intelligence

Biotechnology

Other Technology

Other Education

Software

University

Health

Education

Science

More Like This

Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Owkin, an AI-Biotech Unicorn, Brings Its Cutting-Edge AI to Germany, Austria and Switzerland to Accelerate Research

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Owkin enters collaboration agreement with MSD to develop AI-powered diagnostics for cancer

Owkin Announces Partnership with AstraZeneca to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer

Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare

EP2_4 Receptor (Photo: Business Wire)

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

Owkin Announces MSIntuit® CRC v2, a Next-Generation AI Diagnostic Aimed at Transforming the Detection and Treatment of Colorectal Cancer